Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432003 · ClinicalTrials.gov registry record
Effects of Anti-HIV Therapy on Nervous System Function
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 297
- Enrollment target
NCT00432003 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 297 participants.
The verdict
NCT00432003 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the way two different anti-HIV treatment strategies affect nerve and brain function in adults with HIV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432003
The ClinicalTrials.gov registry entry for NCT00432003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00432003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432003 about?
NCT00432003 is a clinical study titled "Effects of Anti-HIV Therapy on Nervous System Function". The purpose of this study is to observe the way two different anti-HIV treatment strategies affect nerve and brain function in adults with HIV.
What is the current status of trial NCT00432003?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2005-03. Estimated completion is 2007-07.
Who is sponsoring clinical trial NCT00432003?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.